Equities

medmix AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert

medmix AG

Actions
Health CareMedical Equipment and Services
  • Price (CHF)11.46
  • Today's Change-0.20 / -1.72%
  • Shares traded39.91k
  • 1 Year change-13.44%
  • Beta1.6915
Data delayed at least 15 minutes, as of Feb 16 2026 16:31 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Medmix AG is a Switzerland-based company primarily engaged in manufacturing of healthcare, dental and beauty devices. The Company operates through two reportable segments: Healthcare along with Consumer and Industrial. Healthcare segment includes design and production of high-precision delivery devices and services within drug delivery, surgery and dental markets. Products include injection pens, surgical delivery devices focusing on trauma bone repair and wound healing tissue treatment and mixing, filling and delivery device systems for the dental consumable industry. Consumer and Industrial segment consists of design and production of high precision delivery devices within industry business unit, this includes adhesives used in construction, electronics, automotive, aerospace and various industries, and consumer markets such as beauty and other microbrush applications.

  • Revenue in CHF (TTM)468.10m
  • Net income in CHF-5.80m
  • Incorporated2021
  • Employees2.67k
  • Location
    medmix AGNeuhofstrasse 20BAAR 6340SwitzerlandCHE
  • Phone+41 417237300
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medistim ASA54.03m11.51m286.01m154.0024.788.4320.955.297.797.7936.5622.911.250.76799.674,341,637.0026.7221.9833.0927.1981.2178.6621.3020.322.03--0.048485.046.889.120.00878.1112.5316.89
CellaVision AB65.30m13.17m314.78m236.0023.904.1219.024.826.426.4231.8237.210.72012.026.80--14.5214.7116.2216.9668.5068.3820.1719.852.9725.880.028141.974.949.998.7811.3420.7629.67
COLTENE Holding AG240.71m14.31m328.66m1.18k22.963.6315.601.372.402.4040.2215.131.311.346.40204,684.507.8010.5914.2618.4366.1162.195.957.640.70437.620.360685.663.06-1.7971.310.4306-15.4510.76
IVF Hartmann Holding AG159.45m19.02m348.00m309.0018.312.3914.382.187.927.9266.3960.570.89643.287.88526,221.1010.697.9012.919.6855.7154.0611.939.133.79--0.004248.547.332.8534.0210.78-28.9419.92
Ion Beam Applications SA543.58m15.49m425.43m2.10k27.163.8015.840.78270.56770.567720.174.060.97562.733.28281,693.602.781.5012.034.6431.2134.392.852.150.62097.410.363170.816.7512.01201.573.997.6925.86
Revenio Group Oyj99.95m15.85m452.14m247.0028.444.3122.764.520.6540.6544.124.310.75153.057.26444,129.6011.9214.0014.2317.4070.9270.9515.8619.381.639.660.0969--5.9712.43-5.935.4222.19--
Lumibird SA196.75m9.77m476.93m1.07k48.802.6217.202.420.47750.47759.618.900.50770.95934.42202,198.502.522.513.113.1763.8961.894.974.901.643.160.45830.001.7513.34-20.08-8.3815.27--
medmix AG468.10m-5.80m481.12m2.67k--1.129.881.03-0.1696-0.169611.6010.390.47073.565.86174,403.90-0.49271.27-0.61991.5534.5235.24-1.052.651.101.870.4268140.79-0.55492.84-2,566.67--6.02--
RaySearch Laboratories AB (publ)115.65m19.60m491.28m458.0027.896.4511.014.256.656.6539.2528.740.65846.252.932,935,074.0011.165.2616.217.7792.4291.0116.949.701.6664.920.286152.3812.7715.5811.93--0.2213--
Advanced Medical Solutions Group plc230.83m9.56m499.28m1.50k52.051.8615.682.160.04170.04171.011.170.57582.095.57137,690.002.385.092.635.5252.1955.064.1411.151.553.880.242833.4740.6611.64-55.35-17.818.3610.90
Xvivo Perfusion AB69.87m2.16m501.63m198.00232.322.7661.147.180.79680.796825.7667.100.340.89396.134,101,844.001.053.281.123.5273.8173.863.1010.873.681.830.05570.00-1.2535.19-85.39------
Synektik SA114.03m20.47m546.21m203.0026.6811.3323.684.7911.099.2061.8026.121.2211.183.60--21.9620.1136.1032.6734.9831.4017.9513.601.4142.090.153--9.1640.2951.5870.0228.82--
Arjo AB (publ)946.46m28.74m590.38m6.94k22.020.98624.810.62381.231.2340.3927.380.7044.926.221,584,702.002.143.262.914.8042.5943.423.044.780.84944.190.417948.74-2.593.92-32.93-8.68--2.25
Gerresheimer AG2.05bn21.27m625.91m13.54k29.420.49012.460.30530.6760.67665.1540.590.54553.737.85185,328.900.63413.300.87164.6826.8930.041.165.840.52142.080.602241.292.287.90-5.526.3217.58-49.35
Paul Hartmann AG2.21bn74.26m712.79m10.09k9.540.66354.060.322422.9522.95682.93330.051.161.975.54240,745.704.124.215.455.7959.5657.303.563.351.1114.110.246537.952.321.95281.5813.2310.082.71
Data as of Feb 16 2026. Currency figures normalised to medmix AG's reporting currency: Swiss Franc CHF

Institutional shareholders

18.19%Per cent of shares held by top holders
HolderShares% Held
FIL Investment Advisors (UK) Ltd.as of 31 Dec 20242.03m4.91%
UBS Asset Management Switzerland AGas of 18 Dec 20251.25m3.03%
Fidelity Investments Canada ULCas of 30 Nov 20251.10m2.67%
The Vanguard Group, Inc.as of 04 Feb 2026926.13k2.24%
Artisan Partners LPas of 30 Sep 2025490.91k1.19%
Dimensional Fund Advisors LPas of 05 Feb 2026399.13k0.97%
Oddo BHF Asset Management SASas of 30 Jan 2026386.26k0.94%
Z�rcher Kantonalbank (Investment Management)as of 30 Jan 2026352.11k0.85%
Baumann & Cie KmGas of 31 Oct 2025300.00k0.73%
Bellevue Asset Management AGas of 30 Dec 2025272.92k0.66%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.